Invacare Corp (NYSE:IVC)
| 1.00 Delayed Data As of 3:59pm ET |  +0.005 / +0.50%Today’s Change | 0.80 Today|||52-Week Range 8.73 | -63.05% Year-to-Date |
Latest IVC News | Press Releases
| Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates Aug 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.00 |
| Today’s open | 1.01 |
| Day’s range | 1.00 - 1.02 |
| Volume | 220,957 |
| Average volume (3 months) | 620,135 |
| Market cap | $40.6M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -58.31% |
| Earnings growth (this year) | -59.56% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +2.85% |
| P/E ratio | NM |
| Price/Sales | 0.11 |
| Price/Book | 0.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| POAIPredictive Oncology ... | -0.05 | -10.02% |
| SRGASurgalign Holdings I... | +0.05 | +1.07% |
| --Implanet SA | 0.00 | 0.00% |
| NAOVNanovibronix Inc | +0.03 | +3.93% |
Data as of 3:59pm ET, 08/12/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $873.5M |
| Annual profit (last year) | -$45.6M |
| Net profit margin | -5.22% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Elyria, Ohio |
Forecasts
